rs28495775

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001083619.3(GRIA2):​c.230-6153A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.25 in 152,072 control chromosomes in the GnomAD database, including 5,502 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.25 ( 5502 hom., cov: 32)

Consequence

GRIA2
NM_001083619.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.22

Publications

1 publications found
Variant links:
Genes affected
GRIA2 (HGNC:4572): (glutamate ionotropic receptor AMPA type subunit 2) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. This gene product belongs to a family of glutamate receptors that are sensitive to alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA), and function as ligand-activated cation channels. These channels are assembled from 4 related subunits, GRIA1-4. The subunit encoded by this gene (GRIA2) is subject to RNA editing (CAG->CGG; Q->R) within the second transmembrane domain, which is thought to render the channel impermeable to Ca(2+). Human and animal studies suggest that pre-mRNA editing is essential for brain function, and defective GRIA2 RNA editing at the Q/R site may be relevant to amyotrophic lateral sclerosis (ALS) etiology. Alternative splicing, resulting in transcript variants encoding different isoforms, (including the flip and flop isoforms that vary in their signal transduction properties), has been noted for this gene. [provided by RefSeq, Jul 2008]
GRIA2 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with language impairment and behavioral abnormalities
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, G2P, Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.397 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRIA2NM_001083619.3 linkc.230-6153A>G intron_variant Intron 2 of 15 ENST00000264426.14 NP_001077088.2 P42262-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRIA2ENST00000264426.14 linkc.230-6153A>G intron_variant Intron 2 of 15 1 NM_001083619.3 ENSP00000264426.9 P42262-1

Frequencies

GnomAD3 genomes
AF:
0.249
AC:
37894
AN:
151954
Hom.:
5479
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.401
Gnomad AMI
AF:
0.160
Gnomad AMR
AF:
0.184
Gnomad ASJ
AF:
0.218
Gnomad EAS
AF:
0.159
Gnomad SAS
AF:
0.172
Gnomad FIN
AF:
0.190
Gnomad MID
AF:
0.237
Gnomad NFE
AF:
0.196
Gnomad OTH
AF:
0.244
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.250
AC:
37963
AN:
152072
Hom.:
5502
Cov.:
32
AF XY:
0.247
AC XY:
18341
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.402
AC:
16659
AN:
41468
American (AMR)
AF:
0.184
AC:
2809
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.218
AC:
756
AN:
3468
East Asian (EAS)
AF:
0.159
AC:
820
AN:
5162
South Asian (SAS)
AF:
0.172
AC:
829
AN:
4818
European-Finnish (FIN)
AF:
0.190
AC:
2012
AN:
10592
Middle Eastern (MID)
AF:
0.241
AC:
71
AN:
294
European-Non Finnish (NFE)
AF:
0.196
AC:
13344
AN:
68000
Other (OTH)
AF:
0.245
AC:
517
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1380
2760
4139
5519
6899
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
384
768
1152
1536
1920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.152
Hom.:
408
Bravo
AF:
0.257
Asia WGS
AF:
0.195
AC:
678
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.13
DANN
Benign
0.70
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28495775; hg19: chr4-158218551; API